Importantly, several studies have demonstrated that NLRP3 is a potential treatment target in atherosclerosis, as it is involved in pathways that enhance the progression of the disease but are suppressed by NLRP3 inhibitors [23,24]. Here, NLRP3 is linked to atherosclerosis.